In an unprecedented move, scientists and clinicians across Greater Manchester have formed a Rapid Response Research Group to find ways to beat COVID-19 and save lives.
The first global patient has taken part in a clinical trial testing the effectiveness and safety of a new treatment for a rare inflammatory muscle disease. Professor Hector Chinoy is the UK chief investigator of the study and Dr James Lilleker is a sub-investigator. Both are BRC researchers within
Manchester will host the inaugural World Healthcare Congress Europe (5-7 March, 2019), providing a global platform to showcase health and social care innovation. Professor Chris Griffiths will be leading a session on stratified approaches to healthcare session at the Congress.
This event will provide training and advice on how to understand and identify IP, through to realising the commercial impact of the products, processes or services from their research, how to engage with industry in this process and funding opportunities available.
The workshop will present how the BRC Rapid Translation Incubator can support researchers and clinical trial coordinators.
This week the NIHR Manchester Biomedical Research Centre and Clinical Research Facility have launched two new animations aimed at the life sciences industry.
The Manchester BRC and CRF have been chosen as one of 13 centres around England which will contribute to the new NIHR BioResource for Translational Research in Common and Rare Diseases.
This interactive workshop is an opportunity to learn more about the use of data to predict health risks and outcomes for clinical pathway redesign and disease prevention.